Global Bone Morphogenetic Proteins 7 Market Growth 2025-2031

December 2025 | 123 pages | ID: GD7E38CC11B5EN
LP Information

Abstracts

The global Bone Morphogenetic Proteins 7 market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Bone morphogenetic proteins 7 (BMP-7) are a type of growth factor that plays a crucial role in bone formation and regeneration. They are used in certain medical procedures and therapies to promote bone healing and tissue repair.

The market for bone morphogenetic proteins 7 is driven by the demand for advanced bone regeneration solutions, especially in orthopedic and spine surgeries. The market's growth is also influenced by research and developments in biotechnology and regenerative medicine.

LP Information, Inc. (LPI) ' newest research report, the “Bone Morphogenetic Proteins 7 Industry Forecast” looks at past sales and reviews total world Bone Morphogenetic Proteins 7 sales in 2024, providing a comprehensive analysis by region and market sector of projected Bone Morphogenetic Proteins 7 sales for 2025 through 2031. With Bone Morphogenetic Proteins 7 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bone Morphogenetic Proteins 7 industry.

This Insight Report provides a comprehensive analysis of the global Bone Morphogenetic Proteins 7 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bone Morphogenetic Proteins 7 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bone Morphogenetic Proteins 7 market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bone Morphogenetic Proteins 7 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bone Morphogenetic Proteins 7.

This report presents a comprehensive overview, market shares, and growth opportunities of Bone Morphogenetic Proteins 7 market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Sponge
• Gel

Segmentation by Application:

• Spinal Fusion
• Trauma Surgery
• Oral Maxillofacial Surgery
• Reconstructive

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Stryker
• Ember Therapeutics
• Medtronic
• Cellumed Co., Ltd.
• DePuy Synthes
• Integra Lifesciences Holdings Corporation
• R&D Systems
• Merck KGaA
• Smith and Nephew, Inc.
• Thermo Fischer Scientific
• Zimmer Biomet Holdings, Inc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Bone Morphogenetic Proteins 7 market?

What factors are driving Bone Morphogenetic Proteins 7 market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Bone Morphogenetic Proteins 7 market opportunities vary by end market size?

How does Bone Morphogenetic Proteins 7 break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Bone Morphogenetic Proteins 7 Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Bone Morphogenetic Proteins 7 by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Bone Morphogenetic Proteins 7 by Country/Region, 2020, 2024 & 2031
2.2 Bone Morphogenetic Proteins 7 Segment by Type
  2.2.1 Sponge
  2.2.2 Gel
2.3 Bone Morphogenetic Proteins 7 Sales by Type
  2.3.1 Global Bone Morphogenetic Proteins 7 Sales Market Share by Type (2020-2025)
  2.3.2 Global Bone Morphogenetic Proteins 7 Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Bone Morphogenetic Proteins 7 Sale Price by Type (2020-2025)
2.4 Bone Morphogenetic Proteins 7 Segment by Application
  2.4.1 Spinal Fusion
  2.4.2 Trauma Surgery
  2.4.3 Oral Maxillofacial Surgery
  2.4.4 Reconstructive
2.5 Bone Morphogenetic Proteins 7 Sales by Application
  2.5.1 Global Bone Morphogenetic Proteins 7 Sale Market Share by Application (2020-2025)
  2.5.2 Global Bone Morphogenetic Proteins 7 Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Bone Morphogenetic Proteins 7 Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Bone Morphogenetic Proteins 7 Breakdown Data by Company
  3.1.1 Global Bone Morphogenetic Proteins 7 Annual Sales by Company (2020-2025)
  3.1.2 Global Bone Morphogenetic Proteins 7 Sales Market Share by Company (2020-2025)
3.2 Global Bone Morphogenetic Proteins 7 Annual Revenue by Company (2020-2025)
  3.2.1 Global Bone Morphogenetic Proteins 7 Revenue by Company (2020-2025)
  3.2.2 Global Bone Morphogenetic Proteins 7 Revenue Market Share by Company (2020-2025)
3.3 Global Bone Morphogenetic Proteins 7 Sale Price by Company
3.4 Key Manufacturers Bone Morphogenetic Proteins 7 Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Bone Morphogenetic Proteins 7 Product Location Distribution
  3.4.2 Players Bone Morphogenetic Proteins 7 Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR BONE MORPHOGENETIC PROTEINS 7 BY GEOGRAPHIC REGION

4.1 World Historic Bone Morphogenetic Proteins 7 Market Size by Geographic Region (2020-2025)
  4.1.1 Global Bone Morphogenetic Proteins 7 Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Bone Morphogenetic Proteins 7 Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Bone Morphogenetic Proteins 7 Market Size by Country/Region (2020-2025)
  4.2.1 Global Bone Morphogenetic Proteins 7 Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Bone Morphogenetic Proteins 7 Annual Revenue by Country/Region (2020-2025)
4.3 Americas Bone Morphogenetic Proteins 7 Sales Growth
4.4 APAC Bone Morphogenetic Proteins 7 Sales Growth
4.5 Europe Bone Morphogenetic Proteins 7 Sales Growth
4.6 Middle East & Africa Bone Morphogenetic Proteins 7 Sales Growth

5 AMERICAS

5.1 Americas Bone Morphogenetic Proteins 7 Sales by Country
  5.1.1 Americas Bone Morphogenetic Proteins 7 Sales by Country (2020-2025)
  5.1.2 Americas Bone Morphogenetic Proteins 7 Revenue by Country (2020-2025)
5.2 Americas Bone Morphogenetic Proteins 7 Sales by Type (2020-2025)
5.3 Americas Bone Morphogenetic Proteins 7 Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Bone Morphogenetic Proteins 7 Sales by Region
  6.1.1 APAC Bone Morphogenetic Proteins 7 Sales by Region (2020-2025)
  6.1.2 APAC Bone Morphogenetic Proteins 7 Revenue by Region (2020-2025)
6.2 APAC Bone Morphogenetic Proteins 7 Sales by Type (2020-2025)
6.3 APAC Bone Morphogenetic Proteins 7 Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Bone Morphogenetic Proteins 7 by Country
  7.1.1 Europe Bone Morphogenetic Proteins 7 Sales by Country (2020-2025)
  7.1.2 Europe Bone Morphogenetic Proteins 7 Revenue by Country (2020-2025)
7.2 Europe Bone Morphogenetic Proteins 7 Sales by Type (2020-2025)
7.3 Europe Bone Morphogenetic Proteins 7 Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Bone Morphogenetic Proteins 7 by Country
  8.1.1 Middle East & Africa Bone Morphogenetic Proteins 7 Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Bone Morphogenetic Proteins 7 Revenue by Country (2020-2025)
8.2 Middle East & Africa Bone Morphogenetic Proteins 7 Sales by Type (2020-2025)
8.3 Middle East & Africa Bone Morphogenetic Proteins 7 Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bone Morphogenetic Proteins
10.3 Manufacturing Process Analysis of Bone Morphogenetic Proteins
10.4 Industry Chain Structure of Bone Morphogenetic Proteins

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Bone Morphogenetic Proteins 7 Distributors
11.3 Bone Morphogenetic Proteins 7 Customer

12 WORLD FORECAST REVIEW FOR BONE MORPHOGENETIC PROTEINS 7 BY GEOGRAPHIC REGION

12.1 Global Bone Morphogenetic Proteins 7 Market Size Forecast by Region
  12.1.1 Global Bone Morphogenetic Proteins 7 Forecast by Region (2026-2031)
  12.1.2 Global Bone Morphogenetic Proteins 7 Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Bone Morphogenetic Proteins 7 Forecast by Type (2026-2031)
12.7 Global Bone Morphogenetic Proteins 7 Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Stryker
  13.1.1 Stryker Company Information
  13.1.2 Stryker Bone Morphogenetic Proteins 7 Product Portfolios and Specifications
  13.1.3 Stryker Bone Morphogenetic Proteins 7 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Stryker Main Business Overview
  13.1.5 Stryker Latest Developments
13.2 Ember Therapeutics
  13.2.1 Ember Therapeutics Company Information
  13.2.2 Ember Therapeutics Bone Morphogenetic Proteins 7 Product Portfolios and Specifications
  13.2.3 Ember Therapeutics Bone Morphogenetic Proteins 7 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Ember Therapeutics Main Business Overview
  13.2.5 Ember Therapeutics Latest Developments
13.3 Medtronic
  13.3.1 Medtronic Company Information
  13.3.2 Medtronic Bone Morphogenetic Proteins 7 Product Portfolios and Specifications
  13.3.3 Medtronic Bone Morphogenetic Proteins 7 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Medtronic Main Business Overview
  13.3.5 Medtronic Latest Developments
13.4 Cellumed Co., Ltd.
  13.4.1 Cellumed Co., Ltd. Company Information
  13.4.2 Cellumed Co., Ltd. Bone Morphogenetic Proteins 7 Product Portfolios and Specifications
  13.4.3 Cellumed Co., Ltd. Bone Morphogenetic Proteins 7 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Cellumed Co., Ltd. Main Business Overview
  13.4.5 Cellumed Co., Ltd. Latest Developments
13.5 DePuy Synthes
  13.5.1 DePuy Synthes Company Information
  13.5.2 DePuy Synthes Bone Morphogenetic Proteins 7 Product Portfolios and Specifications
  13.5.3 DePuy Synthes Bone Morphogenetic Proteins 7 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 DePuy Synthes Main Business Overview
  13.5.5 DePuy Synthes Latest Developments
13.6 Integra Lifesciences Holdings Corporation
  13.6.1 Integra Lifesciences Holdings Corporation Company Information
  13.6.2 Integra Lifesciences Holdings Corporation Bone Morphogenetic Proteins 7 Product Portfolios and Specifications
  13.6.3 Integra Lifesciences Holdings Corporation Bone Morphogenetic Proteins 7 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Integra Lifesciences Holdings Corporation Main Business Overview
  13.6.5 Integra Lifesciences Holdings Corporation Latest Developments
13.7 R&D Systems
  13.7.1 R&D Systems Company Information
  13.7.2 R&D Systems Bone Morphogenetic Proteins 7 Product Portfolios and Specifications
  13.7.3 R&D Systems Bone Morphogenetic Proteins 7 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 R&D Systems Main Business Overview
  13.7.5 R&D Systems Latest Developments
13.8 Merck KGaA
  13.8.1 Merck KGaA Company Information
  13.8.2 Merck KGaA Bone Morphogenetic Proteins 7 Product Portfolios and Specifications
  13.8.3 Merck KGaA Bone Morphogenetic Proteins 7 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Merck KGaA Main Business Overview
  13.8.5 Merck KGaA Latest Developments
13.9 Smith and Nephew, Inc.
  13.9.1 Smith and Nephew, Inc. Company Information
  13.9.2 Smith and Nephew, Inc. Bone Morphogenetic Proteins 7 Product Portfolios and Specifications
  13.9.3 Smith and Nephew, Inc. Bone Morphogenetic Proteins 7 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Smith and Nephew, Inc. Main Business Overview
  13.9.5 Smith and Nephew, Inc. Latest Developments
13.10 Thermo Fischer Scientific
  13.10.1 Thermo Fischer Scientific Company Information
  13.10.2 Thermo Fischer Scientific Bone Morphogenetic Proteins 7 Product Portfolios and Specifications
  13.10.3 Thermo Fischer Scientific Bone Morphogenetic Proteins 7 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Thermo Fischer Scientific Main Business Overview
  13.10.5 Thermo Fischer Scientific Latest Developments
13.11 Zimmer Biomet Holdings, Inc.
  13.11.1 Zimmer Biomet Holdings, Inc. Company Information
  13.11.2 Zimmer Biomet Holdings, Inc. Bone Morphogenetic Proteins 7 Product Portfolios and Specifications
  13.11.3 Zimmer Biomet Holdings, Inc. Bone Morphogenetic Proteins 7 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 Zimmer Biomet Holdings, Inc. Main Business Overview
  13.11.5 Zimmer Biomet Holdings, Inc. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Bone Morphogenetic Proteins 7 Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Bone Morphogenetic Proteins 7 Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Sponge
Table 4. Major Players of Gel
Table 5. Global Bone Morphogenetic Proteins 7 Sales by Type (2020-2025) & (K MT)
Table 6. Global Bone Morphogenetic Proteins 7 Sales Market Share by Type (2020-2025)
Table 7. Global Bone Morphogenetic Proteins 7 Revenue by Type (2020-2025) & ($ million)
Table 8. Global Bone Morphogenetic Proteins 7 Revenue Market Share by Type (2020-2025)
Table 9. Global Bone Morphogenetic Proteins 7 Sale Price by Type (2020-2025) & (US$/Ton)
Table 10. Global Bone Morphogenetic Proteins 7 Sale by Application (2020-2025) & (K MT)
Table 11. Global Bone Morphogenetic Proteins 7 Sale Market Share by Application (2020-2025)
Table 12. Global Bone Morphogenetic Proteins 7 Revenue by Application (2020-2025) & ($ million)
Table 13. Global Bone Morphogenetic Proteins 7 Revenue Market Share by Application (2020-2025)
Table 14. Global Bone Morphogenetic Proteins 7 Sale Price by Application (2020-2025) & (US$/Ton)
Table 15. Global Bone Morphogenetic Proteins 7 Sales by Company (2020-2025) & (K MT)
Table 16. Global Bone Morphogenetic Proteins 7 Sales Market Share by Company (2020-2025)
Table 17. Global Bone Morphogenetic Proteins 7 Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Bone Morphogenetic Proteins 7 Revenue Market Share by Company (2020-2025)
Table 19. Global Bone Morphogenetic Proteins 7 Sale Price by Company (2020-2025) & (US$/Ton)
Table 20. Key Manufacturers Bone Morphogenetic Proteins 7 Producing Area Distribution and Sales Area
Table 21. Players Bone Morphogenetic Proteins 7 Products Offered
Table 22. Bone Morphogenetic Proteins 7 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Bone Morphogenetic Proteins 7 Sales by Geographic Region (2020-2025) & (K MT)
Table 26. Global Bone Morphogenetic Proteins 7 Sales Market Share Geographic Region (2020-2025)
Table 27. Global Bone Morphogenetic Proteins 7 Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Bone Morphogenetic Proteins 7 Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Bone Morphogenetic Proteins 7 Sales by Country/Region (2020-2025) & (K MT)
Table 30. Global Bone Morphogenetic Proteins 7 Sales Market Share by Country/Region (2020-2025)
Table 31. Global Bone Morphogenetic Proteins 7 Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Bone Morphogenetic Proteins 7 Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Bone Morphogenetic Proteins 7 Sales by Country (2020-2025) & (K MT)
Table 34. Americas Bone Morphogenetic Proteins 7 Sales Market Share by Country (2020-2025)
Table 35. Americas Bone Morphogenetic Proteins 7 Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Bone Morphogenetic Proteins 7 Sales by Type (2020-2025) & (K MT)
Table 37. Americas Bone Morphogenetic Proteins 7 Sales by Application (2020-2025) & (K MT)
Table 38. APAC Bone Morphogenetic Proteins 7 Sales by Region (2020-2025) & (K MT)
Table 39. APAC Bone Morphogenetic Proteins 7 Sales Market Share by Region (2020-2025)
Table 40. APAC Bone Morphogenetic Proteins 7 Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Bone Morphogenetic Proteins 7 Sales by Type (2020-2025) & (K MT)
Table 42. APAC Bone Morphogenetic Proteins 7 Sales by Application (2020-2025) & (K MT)
Table 43. Europe Bone Morphogenetic Proteins 7 Sales by Country (2020-2025) & (K MT)
Table 44. Europe Bone Morphogenetic Proteins 7 Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Bone Morphogenetic Proteins 7 Sales by Type (2020-2025) & (K MT)
Table 46. Europe Bone Morphogenetic Proteins 7 Sales by Application (2020-2025) & (K MT)
Table 47. Middle East & Africa Bone Morphogenetic Proteins 7 Sales by Country (2020-2025) & (K MT)
Table 48. Middle East & Africa Bone Morphogenetic Proteins 7 Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Bone Morphogenetic Proteins 7 Sales by Type (2020-2025) & (K MT)
Table 50. Middle East & Africa Bone Morphogenetic Proteins 7 Sales by Application (2020-2025) & (K MT)
Table 51. Key Market Drivers & Growth Opportunities of Bone Morphogenetic Proteins 7
Table 52. Key Market Challenges & Risks of Bone Morphogenetic Proteins 7
Table 53. Key Industry Trends of Bone Morphogenetic Proteins 7
Table 54. Bone Morphogenetic Proteins 7 Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Bone Morphogenetic Proteins 7 Distributors List
Table 57. Bone Morphogenetic Proteins 7 Customer List
Table 58. Global Bone Morphogenetic Proteins 7 Sales Forecast by Region (2026-2031) & (K MT)
Table 59. Global Bone Morphogenetic Proteins 7 Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Bone Morphogenetic Proteins 7 Sales Forecast by Country (2026-2031) & (K MT)
Table 61. Americas Bone Morphogenetic Proteins 7 Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Bone Morphogenetic Proteins 7 Sales Forecast by Region (2026-2031) & (K MT)
Table 63. APAC Bone Morphogenetic Proteins 7 Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Bone Morphogenetic Proteins 7 Sales Forecast by Country (2026-2031) & (K MT)
Table 65. Europe Bone Morphogenetic Proteins 7 Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Bone Morphogenetic Proteins 7 Sales Forecast by Country (2026-2031) & (K MT)
Table 67. Middle East & Africa Bone Morphogenetic Proteins 7 Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Bone Morphogenetic Proteins 7 Sales Forecast by Type (2026-2031) & (K MT)
Table 69. Global Bone Morphogenetic Proteins 7 Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Bone Morphogenetic Proteins 7 Sales Forecast by Application (2026-2031) & (K MT)
Table 71. Global Bone Morphogenetic Proteins 7 Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Stryker Basic Information, Bone Morphogenetic Proteins 7 Manufacturing Base, Sales Area and Its Competitors
Table 73. Stryker Bone Morphogenetic Proteins 7 Product Portfolios and Specifications
Table 74. Stryker Bone Morphogenetic Proteins 7 Sales (K MT), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Stryker Main Business
Table 76. Stryker Latest Developments
Table 77. Ember Therapeutics Basic Information, Bone Morphogenetic Proteins 7 Manufacturing Base, Sales Area and Its Competitors
Table 78. Ember Therapeutics Bone Morphogenetic Proteins 7 Product Portfolios and Specifications
Table 79. Ember Therapeutics Bone Morphogenetic Proteins 7 Sales (K MT), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 80. Ember Therapeutics Main Business
Table 81. Ember Therapeutics Latest Developments
Table 82. Medtronic Basic Information, Bone Morphogenetic Proteins 7 Manufacturing Base, Sales Area and Its Competitors
Table 83. Medtronic Bone Morphogenetic Proteins 7 Product Portfolios and Specifications
Table 84. Medtronic Bone Morphogenetic Proteins 7 Sales (K MT), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 85. Medtronic Main Business
Table 86. Medtronic Latest Developments
Table 87. Cellumed Co., Ltd. Basic Information, Bone Morphogenetic Proteins 7 Manufacturing Base, Sales Area and Its Competitors
Table 88. Cellumed Co., Ltd. Bone Morphogenetic Proteins 7 Product Portfolios and Specifications
Table 89. Cellumed Co., Ltd. Bone Morphogenetic Proteins 7 Sales (K MT), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 90. Cellumed Co., Ltd. Main Business
Table 91. Cellumed Co., Ltd. Latest Developments
Table 92. DePuy Synthes Basic Information, Bone Morphogenetic Proteins 7 Manufacturing Base, Sales Area and Its Competitors
Table 93. DePuy Synthes Bone Morphogenetic Proteins 7 Product Portfolios and Specifications
Table 94. DePuy Synthes Bone Morphogenetic Proteins 7 Sales (K MT), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 95. DePuy Synthes Main Business
Table 96. DePuy Synthes Latest Developments
Table 97. Integra Lifesciences Holdings Corporation Basic Information, Bone Morphogenetic Proteins 7 Manufacturing Base, Sales Area and Its Competitors
Table 98. Integra Lifesciences Holdings Corporation Bone Morphogenetic Proteins 7 Product Portfolios and Specifications
Table 99. Integra Lifesciences Holdings Corporation Bone Morphogenetic Proteins 7 Sales (K MT), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 100. Integra Lifesciences Holdings Corporation Main Business
Table 101. Integra Lifesciences Holdings Corporation Latest Developments
Table 102. R&D Systems Basic Information, Bone Morphogenetic Proteins 7 Manufacturing Base, Sales Area and Its Competitors
Table 103. R&D Systems Bone Morphogenetic Proteins 7 Product Portfolios and Specifications
Table 104. R&D Systems Bone Morphogenetic Proteins 7 Sales (K MT), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 105. R&D Systems Main Business
Table 106. R&D Systems Latest Developments
Table 107. Merck KGaA Basic Information, Bone Morphogenetic Proteins 7 Manufacturing Base, Sales Area and Its Competitors
Table 108. Merck KGaA Bone Morphogenetic Proteins 7 Product Portfolios and Specifications
Table 109. Merck KGaA Bone Morphogenetic Proteins 7 Sales (K MT), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 110. Merck KGaA Main Business
Table 111. Merck KGaA Latest Developments
Table 112. Smith and Nephew, Inc. Basic Information, Bone Morphogenetic Proteins 7 Manufacturing Base, Sales Area and Its Competitors
Table 113. Smith and Nephew, Inc. Bone Morphogenetic Proteins 7 Product Portfolios and Specifications
Table 114. Smith and Nephew, Inc. Bone Morphogenetic Proteins 7 Sales (K MT), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 115. Smith and Nephew, Inc. Main Business
Table 116. Smith and Nephew, Inc. Latest Developments
Table 117. Thermo Fischer Scientific Basic Information, Bone Morphogenetic Proteins 7 Manufacturing Base, Sales Area and Its Competitors
Table 118. Thermo Fischer Scientific Bone Morphogenetic Proteins 7 Product Portfolios and Specifications
Table 119. Thermo Fischer Scientific Bone Morphogenetic Proteins 7 Sales (K MT), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 120. Thermo Fischer Scientific Main Business
Table 121. Thermo Fischer Scientific Latest Developments
Table 122. Zimmer Biomet Holdings, Inc. Basic Information, Bone Morphogenetic Proteins 7 Manufacturing Base, Sales Area and Its Competitors
Table 123. Zimmer Biomet Holdings, Inc. Bone Morphogenetic Proteins 7 Product Portfolios and Specifications
Table 124. Zimmer Biomet Holdings, Inc. Bone Morphogenetic Proteins 7 Sales (K MT), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 125. Zimmer Biomet Holdings, Inc. Main Business
Table 126. Zimmer Biomet Holdings, Inc. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Bone Morphogenetic Proteins 7
Figure 2. Bone Morphogenetic Proteins 7 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bone Morphogenetic Proteins 7 Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global Bone Morphogenetic Proteins 7 Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Bone Morphogenetic Proteins 7 Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Bone Morphogenetic Proteins 7 Sales Market Share by Country/Region (2024)
Figure 10. Bone Morphogenetic Proteins 7 Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Sponge
Figure 12. Product Picture of Gel
Figure 13. Global Bone Morphogenetic Proteins 7 Sales Market Share by Type in 2025
Figure 14. Global Bone Morphogenetic Proteins 7 Revenue Market Share by Type (2020-2025)
Figure 15. Bone Morphogenetic Proteins 7 Consumed in Spinal Fusion
Figure 16. Global Bone Morphogenetic Proteins 7 Market: Spinal Fusion (2020-2025) & (K MT)
Figure 17. Bone Morphogenetic Proteins 7 Consumed in Trauma Surgery
Figure 18. Global Bone Morphogenetic Proteins 7 Market: Trauma Surgery (2020-2025) & (K MT)
Figure 19. Bone Morphogenetic Proteins 7 Consumed in Oral Maxillofacial Surgery
Figure 20. Global Bone Morphogenetic Proteins 7 Market: Oral Maxillofacial Surgery (2020-2025) & (K MT)
Figure 21. Bone Morphogenetic Proteins 7 Consumed in Reconstructive
Figure 22. Global Bone Morphogenetic Proteins 7 Market: Reconstructive (2020-2025) & (K MT)
Figure 23. Global Bone Morphogenetic Proteins 7 Sale Market Share by Application (2024)
Figure 24. Global Bone Morphogenetic Proteins 7 Revenue Market Share by Application in 2025
Figure 25. Bone Morphogenetic Proteins 7 Sales by Company in 2025 (K MT)
Figure 26. Global Bone Morphogenetic Proteins 7 Sales Market Share by Company in 2025
Figure 27. Bone Morphogenetic Proteins 7 Revenue by Company in 2025 ($ millions)
Figure 28. Global Bone Morphogenetic Proteins 7 Revenue Market Share by Company in 2025
Figure 29. Global Bone Morphogenetic Proteins 7 Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Bone Morphogenetic Proteins 7 Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Bone Morphogenetic Proteins 7 Sales 2020-2025 (K MT)
Figure 32. Americas Bone Morphogenetic Proteins 7 Revenue 2020-2025 ($ millions)
Figure 33. APAC Bone Morphogenetic Proteins 7 Sales 2020-2025 (K MT)
Figure 34. APAC Bone Morphogenetic Proteins 7 Revenue 2020-2025 ($ millions)
Figure 35. Europe Bone Morphogenetic Proteins 7 Sales 2020-2025 (K MT)
Figure 36. Europe Bone Morphogenetic Proteins 7 Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Bone Morphogenetic Proteins 7 Sales 2020-2025 (K MT)
Figure 38. Middle East & Africa Bone Morphogenetic Proteins 7 Revenue 2020-2025 ($ millions)
Figure 39. Americas Bone Morphogenetic Proteins 7 Sales Market Share by Country in 2025
Figure 40. Americas Bone Morphogenetic Proteins 7 Revenue Market Share by Country (2020-2025)
Figure 41. Americas Bone Morphogenetic Proteins 7 Sales Market Share by Type (2020-2025)
Figure 42. Americas Bone Morphogenetic Proteins 7 Sales Market Share by Application (2020-2025)
Figure 43. United States Bone Morphogenetic Proteins 7 Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Bone Morphogenetic Proteins 7 Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Bone Morphogenetic Proteins 7 Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Bone Morphogenetic Proteins 7 Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Bone Morphogenetic Proteins 7 Sales Market Share by Region in 2025
Figure 48. APAC Bone Morphogenetic Proteins 7 Revenue Market Share by Region (2020-2025)
Figure 49. APAC Bone Morphogenetic Proteins 7 Sales Market Share by Type (2020-2025)
Figure 50. APAC Bone Morphogenetic Proteins 7 Sales Market Share by Application (2020-2025)
Figure 51. China Bone Morphogenetic Proteins 7 Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Bone Morphogenetic Proteins 7 Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Bone Morphogenetic Proteins 7 Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Bone Morphogenetic Proteins 7 Revenue Growth 2020-2025 ($ millions)
Figure 55. India Bone Morphogenetic Proteins 7 Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Bone Morphogenetic Proteins 7 Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Bone Morphogenetic Proteins 7 Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Bone Morphogenetic Proteins 7 Sales Market Share by Country in 2025
Figure 59. Europe Bone Morphogenetic Proteins 7 Revenue Market Share by Country (2020-2025)
Figure 60. Europe Bone Morphogenetic Proteins 7 Sales Market Share by Type (2020-2025)
Figure 61. Europe Bone Morphogenetic Proteins 7 Sales Market Share by Application (2020-2025)
Figure 62. Germany Bone Morphogenetic Proteins 7 Revenue Growth 2020-2025 ($ millions)
Figure 63. France Bone Morphogenetic Proteins 7 Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Bone Morphogenetic Proteins 7 Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Bone Morphogenetic Proteins 7 Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Bone Morphogenetic Proteins 7 Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Bone Morphogenetic Proteins 7 Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Bone Morphogenetic Proteins 7 Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Bone Morphogenetic Proteins 7 Sales Market Share by Application (2020-2025)
Figure 70. Egypt Bone Morphogenetic Proteins 7 Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Bone Morphogenetic Proteins 7 Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Bone Morphogenetic Proteins 7 Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Bone Morphogenetic Proteins 7 Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Bone Morphogenetic Proteins 7 Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Bone Morphogenetic Proteins 7 in 2025
Figure 76. Manufacturing Process Analysis of Bone Morphogenetic Proteins 7
Figure 77. Industry Chain Structure of Bone Morphogenetic Proteins 7
Figure 78. Channels of Distribution
Figure 79. Global Bone Morphogenetic Proteins 7 Sales Market Forecast by Region (2026-2031)
Figure 80. Global Bone Morphogenetic Proteins 7 Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Bone Morphogenetic Proteins 7 Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Bone Morphogenetic Proteins 7 Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Bone Morphogenetic Proteins 7 Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Bone Morphogenetic Proteins 7 Revenue Market Share Forecast by Application (2026-2031)